Oncodesign Services

Oncodesign Services is a biotechnology company based in Dijon, France, founded in 1995, that specializes in research and development of innovative therapeutic and diagnostic tools. The company collaborates with pharmaceutical firms, biotech companies, public research institutions, and investment groups to provide integrated drug discovery services, including in vitro and in vivo pharmacology, metabolism studies, and biomarker development. Oncodesign focuses on anticancer therapies, particularly through its unique precision medicine platform, which addresses challenges in treatment resistance and aims to improve therapeutic outcomes. In addition to drug discovery, the company engages in kinase inhibitor development and has strategic partnerships for research on conditions such as Parkinson's disease. Oncodesign also incorporates artificial intelligence to enhance the drug development process, striving to reduce research times for new drug candidates. Its diverse range of services and expertise positions Oncodesign as a vital player in advancing medical therapies for high-need diseases.